Private equity firm Creador in talks to buy into generic drug co Leeford Health
· economictimes.indiatimes.com
Private equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acquisition would value the generic drugmaker at ₹8,000-₹8,500 crore. Leeford Healthcare is a diversified pharmaceutical and wellness company. This deal marks the company's first ownership dilution to an external investor.
ET Bureau A Kuala Lumpur-based company’s proposed 10% stake purchase would value Leeford at around ₹8,500 crore. (Infographic Image)
Live Events
as a Re...